Search company, investor...

Thiakis

thiakis.com

Founded Year

2004

Stage

Acquired | Acquired

Valuation

$0000 

About Thiakis

Wyeth pharmaceuticals aims to bring health care products and resources, medication information and patient education to consumers and health care professionals.

Headquarters Location

Crown House 72 Hammersmith Road

W14 8TH,

United Kingdom

Missing: Thiakis's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Thiakis's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Thiakis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Thiakis is included in 1 Expert Collection, including Pharma Supply Chain.

P

Pharma Supply Chain

1,258 items

Latest Thiakis News

Burt Zweigenhaft to Retire from Onco360

Feb 6, 2015

Thiakis’ origins, Bloom and acquisition by Wyeth “As a veteran of the pharmacy healthcare industry for over thirty years, I am most proud of what we have been able to accomplish with Onco360. Moving the needle to provide best practices in care for cancer patients has been my passion since joining the Company, and to see this passion for what we do resonate and become industry standard in the national cancer care marketplace, has been extremely fulfilling for me.” Mr. Zweigenhaft stated. “As the Company continues its promising growth, I am fully confident in the direction and leadership of Onco360 as it enters the next phase of its extraordinary development,” Mr. Zweigenhaft went on to say. “Burt leaves a legacy of a unique business model and high-performing organization adding value to the healthcare system through its support of patients suffering from highly complex diseases. We will continue to build on the great clinical, operational, and customer service assets that Onco360 has become known for in the industry. I want to personally thank Burt for his leadership, commitment, and loyalty over the past 9 years,” said Paul Jardina, Onco360 President and CEO. Mr. Zweigenhaft will continue to stay involved in industry leadership roles serving as Co-Chairman of the Association of Value Based Cancer Care, Vice President of the National Specialty Pharmacy Association and continuing philanthropically to serve as a Board Member of Swim Across America for Cancer funding cancer research. About Onco360® Oncology Pharmacy: Onco360 ( http://onco360.com ) is one of the largest independent providers of Oncology Pharmacy services in the country. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. The Company’s clinical and dispensing model was developed specifically to meet the unique needs of oncology-treating physicians and their patients. Onco360 is advancing the continuum of oncology pharmaceutical care through patient advocacy, dispensing excellence, and the clinical experience and expertise that comes from its focus in oncology. Onco360 is headquartered in Louisville, KY and dispenses nationally through its network of JCAHO-accredited Oncology Pharmacies. PharMerica Corporation (NYSE:PMC), a leading institutional pharmacy, specialty infusion and hospital services company servicing healthcare facilities in the United States, made a significant strategic investment in Onco360 in December 2013. Onco360®

Thiakis Frequently Asked Questions (FAQ)

  • When was Thiakis founded?

    Thiakis was founded in 2004.

  • What is Thiakis's latest funding round?

    Thiakis's latest funding round is Acquired.

  • Who are the investors of Thiakis?

    Investors of Thiakis include Wyeth, Consensus Business Group, Esperante, Royal Society Enterprise Fund, NPI Ventures and 5 more.

  • Who are Thiakis's competitors?

    Competitors of Thiakis include Intas Pharmaceuticals, Tubilux Pharma, Histogen, Itaconix, Humanigen and 13 more.

Compare Thiakis to Competitors

E
Entomed, S.A.

Entomed designs and develops antibiotics derived from insects.

I
INDENA SPA

Indena is a company dedicated to the identification, development and production of active principles derived from plants, for use in the pharmaceutical, health-food and cosmetics industries. Indena, a privately owned Italian company, has around 700 employees, including 10% dedicated to full-time research, aims to manage cultivation, manufacturing, and distribution operations in more than 40 countries throughout the world. The key to Indena's success is its research, covering: the screening of medicinal plants for their pharmacological benefits; the identification of new active principles; and the development of extraction and purification systems at the cutting-edge of industrial application. The phyto-chemical research is carried out in Indena's own Research Center in Settala, Italy. Indena also co-operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase I. One of the main strategic objectives of the research is the development of new active principles for pharmaceutical applications. This is also an indispensable base for the health-food and cosmetics industries. In the pharmaceutical sector Indena is currently focusing on the development of anti-cancer treatments, following the successes of paclitaxel, as well as on anti-microbial and on anti-viral drugs. Also under study are active principles for the treatment of pathologies and dysfunction of the central nervous system, such as depression, anxiety, impotence, sleep disorders, and algesia. Today Indena is also concentrating its efforts on the industrial production of high-quality standardised active principles derived from plants, which are important ingredients in health food products. In fact, the company produces standardised extracts from edible plants that are traditionally recognised as having therapeutic properties, as well as from plants that have proven pharmacological value. Indena's research and production activities are particularly attentive to plant-based principles that have anti-oxidant properties and are effective in preventing damage caused by free radicals. Backed by over 80 years of botanical experience, the Italian company has developed a plantation network, managed by experts, to supply its research and production centers with officinal plants, while at the same time ensuring bio-diversity and protecting the ecosystem balance from uncontrolled harvesting. Today more than 60% of the raw material used in the manufacturing process comes from cultivation. Indena's decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations, through constant communication and interaction between the company's experts and the major international regulatory authorities such as WHO, EMEA, and ESCOP, and main pharmacopoeias.

X
Xanodyne Pharmaceuticals

Xanodyne Pharmaceuticalsis a speciality pharmaceutical company focused on products for women's health care and pain management.

A
Albea Pharmaceuticals

Through a series of acquisitions, Albea Pharmaceuticals intends to build a rapidly growing, profitable, and pan-European pharmaceutical company with a portfolio of marketed products, a direct sales and marketing organization in the major European countries (UK, Germany, France, Italy and Spain), and a pipeline of products in various stages of clinical development.'

Azur Pharma Logo
Azur Pharma

Azur Pharma is a pharmaceutical company focused on the CNS, women's health and urology markets of the US.

T
Total Pharmaceutical Care

Total Pharmaceutical Care, Inc. offers home healthcare and infusion therapy services

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.